Loading…

Role of extracellular signal-regulated kinase and phosphatidylinositol-3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis

The present study examined the role of mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3 kinase-stimulated Akt (PI-3K/Akt) in the regulation of constitutive human neutrophil apoptosis by bacterial lipopolysaccharide (LPS) and two chemoattractants, fMLP and leukotriene B 4 (LTB 4)....

Full description

Saved in:
Bibliographic Details
Published in:Cellular signalling 2001-05, Vol.13 (5), p.335-343
Main Authors: Klein, Jon B, Buridi, Abdul, Coxon, Patricia Y, Rane, Madhavi J, Manning, Terri, Kettritz, Ralph, McLeish, Kenneth R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present study examined the role of mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3 kinase-stimulated Akt (PI-3K/Akt) in the regulation of constitutive human neutrophil apoptosis by bacterial lipopolysaccharide (LPS) and two chemoattractants, fMLP and leukotriene B 4 (LTB 4). LPS and LTB 4 inhibited apoptosis, while fMLP had no effect. Inhibition of extracellular signal-regulated kinase (ERK) with PD098059 significantly inhibited the anti-apoptotic effect of both LPS and LTB 4, while inhibition of p38 kinase with SB203580 had no effect. Inhibition of PI-3K with wortmannin and LY294002 significantly attenuated the anti-apoptotic effect of LTB 4, but not LPS. LPS, fMLP, and LTB 4 stimulated similar levels of ERK and Akt activation. LTB 4 and LPS inhibited neutrophil apoptosis when added simultaneously with fMLP, and LTB 4 and LPS demonstrated an additive effect. We conclude that the ERK and/or PI-3K/Akt pathways are necessary, but not sufficient, for LPS and LTB 4 to delay apoptosis, but other anti-apoptotic pathways remain to be identified.
ISSN:0898-6568
1873-3913
DOI:10.1016/S0898-6568(01)00151-6